Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CEBPA stimulants(CCAAT enhancer binding protein alpha stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H18N2O4 |
InChIKeyOTKDKQJFWIGZLU-ACCUITESSA-N |
CAS Registry2041072-41-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | US | 01 Oct 2015 |